Increases in life expectancy in the u.s. during the twentieth century were due primarily to

  1. Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science. 2002;296:1029–31.

    CAS  Article  PubMed  Google Scholar 

  2. Ikeda N, Saito E, Kondo N, Inoue M, Ikeda S, Satoh T, Wada K, Stickley A, Katanoda K, Mizoue T, Noda M, Iso H, Fujino Y, Sobue T, Tsugane S, Naghavi M, Ezzati M, Shibuya K. What has made the population of Japan healthy? Lancet. 2011;378:1094–105.

    Article  PubMed  Google Scholar 

  3. Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q. 1986;64:355–91.

    CAS  Article  PubMed  Google Scholar 

  4. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Q. 2005;83:731–57.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Houweling TA, Kunst AE, Mackenbach JP. World Health Report 2000: inequality index and socioeconomic inequalities in mortality. Lancet. 2001;357:1671–2.

    CAS  Article  PubMed  Google Scholar 

  6. Pollard JH. On the decomposition of changes in expectation of life and differentials in life expectancy. Demography. 1988;25:265–76.

    CAS  Article  PubMed  Google Scholar 

  7. Mortality database. [//www.who.int/healthinfo/mortality_data/en/]. Accessed 17 May 2016.

  8. Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83:171–7.

    PubMed  PubMed Central  Google Scholar 

  9. Pollard JH. The expectation of life and its relationship to mortality. J Inst Actuaries. 1982;109:225–40.

    Article  Google Scholar 

  10. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1998.

    Google Scholar 

  11. Vaupel JW. The remarkable improvements in survival at older ages. Philos Trans R Soc Lond B Biol Sci. 1997;352:1799–804.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  12. Vaupel JW. Biodemography of human ageing. Nature. 2010;464:536–42.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  13. Lawlor DA, Ebrahim S, Davey Smith G. Sex matters: secular and geographical trends in sex differences in coronary heart disease mortality. BMJ. 2001;323:541–5.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  14. Waldron I. Sex differences in human mortality: the role of genetic factors. Soc Sci Med. 1983;17:321–33.

    CAS  Article  PubMed  Google Scholar 

  15. Owens IPF. Ecology and evolution. Sex differences in mortality rate. Science. 2002;297:2008–9.

    Article  PubMed  Google Scholar 

  16. May RC. Gender, immunity and the regulation of longevity. Bioessays. 2007;29:795–802.

    CAS  Article  PubMed  Google Scholar 

  17. Klenk J, Nagel G, Ulmer H, Strasak A, Concin H, Diem G, Rapp K. Body mass index and mortality: results of a cohort of 184,697 adults in Austria. Eur J Epidemiol. 2009;24:83–91.

    Article  PubMed  Google Scholar 

  18. Lopez AD. The evolution of the Global Burden of Disease framework for disease, injury and risk factor quantification: developing the evidence base for national, regional and global public health action. Glob Health. 2005;1:5.

    Article  Google Scholar 

  19. Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, Mbanya JC, McKee M, Moodie R, Nishtar S, Piot P, Reddy KS, Stuckler D. UN high-level meeting on non-communicable diseases: addressing four questions. Lancet. 2011;378:449–55.

    Article  PubMed  Google Scholar 

  20. WHO. World Health Statistics 2011. Geneva: World Health Organization; 2011.

    Google Scholar 

  21. Marmot MG, Smith GD. Why are the Japanese living longer? BMJ. 1989;299:1547–51.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  22. Murray CJL. Why is Japanese life expectancy so high? Lancet. 2011;378:1124–5.

    Article  PubMed  Google Scholar 

  23. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349:1269–76.

    CAS  Article  PubMed  Google Scholar 

  24. Bonneux LG, Huisman CC, de Beer JA. Mortality in 272 European regions, 2002–2004. An update. Eur J Epidemiol. 2010;25:77–85.

    Article  PubMed  Google Scholar 

  25. Helis E, Augustincic L, Steiner S, Chen L, Turton P, Fodor JG. Time trends in cardiovascular and all-cause mortality in the “old” and “new” European Union countries. Eur J Cardiovasc Prev Rehabil. 2011;18:347–59.

    Article  PubMed  Google Scholar 

  26. Finch CE, Crimmins EM. Inflammatory exposure and historical changes in human life-spans. Science. 2004;305:1736–9.

    CAS  Article  PubMed  Google Scholar 

  27. Notzon FC, Komarov YM, Ermakov SP, Sempos CT, Marks JS, Sempos EV. Causes of declining life expectancy in Russia. JAMA. 1998;279:793–800.

    CAS  Article  PubMed  Google Scholar 

  28. Klenk J, Rapp K, Büchele G, Keil U, Weiland SK. Increasing life expectancy in Germany: quantitative contributions from changes in age- and disease-specific mortality. Eur J Public Health. 2007;17:587–92.

    Article  PubMed  Google Scholar 

  29. Preston SH, Stokes A. Contribution of obesity to international differences in life expectancy. Am J Public Health. 2011;101:2137–43.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Di Cesare M, Khang Y-H, Asaria P, Blakely T, Cowan MJ, Farzadfar F, Guerrero R, Ikeda N, Kyobutungi C, Msyamboza KP, Oum S, Lynch JW, Marmot MG, Ezzati M. Inequalities in non-communicable diseases and effective responses. Lancet. 2013;381:585–97.

    Article  PubMed  Google Scholar 

  31. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, Cecchini M, Colagiuri R, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G, Gaziano T, Geneau R, Haines A, Hospedales J, Jha P, Keeling A, Leeder S, Lincoln P, McKee M, Mackay J, Magnusson R, Moodie R, Mwatsama M, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377:1438–47.

    Article  PubMed  Google Scholar 

  32. Ezzati M, Riboli E. Can noncommunicable diseases be prevented? Lessons from studies of populations and individuals. Science. 2012;337:1482–7.

    Article  PubMed  Google Scholar 

  33. Alleyne G, Binagwaho A, Haines A, Jahan S, Nugent R, Rojhani A, Stuckler D. Embedding non-communicable diseases in the post-2015 development agenda. Lancet. 2013;381:566–74.

    Article  PubMed  Google Scholar 

  34. Bonita R, Magnusson R, Bovet P, Zhao D, Malta DC, Geneau R, Suh I, Thankappan KR, McKee M, Hospedales J, de Courten M, Capewell S, Beaglehole R. Country actions to meet UN commitments on non-communicable diseases: a stepwise approach. Lancet. 2013;381:575–84.

    Article  PubMed  Google Scholar 

Page 2

Country Observation period Total populationa Life expectancy womena, b Life expectancy mena,b Gross national income per capita (US$)a, b Total health expenditure per capita (int $)a, b, c Total health expenditure as % of gross domestic producta, b
Japan 1950–2010 127,450,459 86.3 79.6 42,190 3,237 9.6
Hong Kong SAR 1960–2010 7,024,200 86.0 80.1 33,620 NA NA
France 1955–2005 65,023,142 85.3 78.2 43,790 4,039 11.7
Italy 1955–2000 59,277,417 85.0 79.8 37,690 3,162 9.4
Spain 1955–2010 46,576,897 84.7 78.7 32,130 3,026 9.6
Switzerland 1955–2010 7,824,909 84.5 80.1 77,360 5,319 10.9
Republic of Korea 1985–2010 49,410,366 84.1 77.2 21,320 2,069 7.3
Australia 1950–2000 22,031,800 84.0 79.5 46,490 3,761 8.9
Singapore 1965–2010 5,076,700 84.0 79.2 44,790 2,773 4.1
Israel 1975–2010 7,623,600 83.6 79.7 29,480 2,078 7.6
Sweden 1955–2010 9,378,126 83.5 79.5 53,810 3,762 9.5
Norway 1955–2010 4,889,252 83.2 78.9 86,830 5,475 10.0
Canada 1950–2005 34,005,274 83.2 78.7 44,450 4,468 11.4
Austria 1995–2010 8,389,771 83.2 77.7 49,180 4,517 11.6
Finland 1955–2010 5,363,352 83.2 76.7 49,320 3,297 9.0
Ireland 1950–2005 4,560,155 83.1 78.5 43,760 3,796 9.3
Greece 1965–2010 11,153,454 83.0 77.9 27,580 2,685 9.4
Belgium 1955–1995 10,920,272 83.0 77.6 47,200 4,058 10.5
Netherlands 1950–2010 16,615,394 82.7 78.8 53,320 5,063 12.1
New Zealand 1950–2005 4,367,800 82.7 78.8 28,980 3,034 10.2
Slovenia 1985–2010 2,048,583 82.7 76.3 24,540 2,452 8.9
Germany, Former Federal Republic 1955–1990 1990: 63,253,800 1989: 78.6 1989: 72.1 1990: 20,630 NA NA
Germany 1990–2010 81,776,930 82.6 77.5 44,780 4,426 11.5
United Kingdom 1950–2010 62,766,365 82.4 78.5 40,470 3,223 9.6
Chile 1955–1990 17,150,760 82.1 76.2 10,730 1,309 7.1
Portugal 1955–2000 10,573,100 82.1 76.1 22,930 2,810 10.8
Puerto Rico 1970–1990 3,721,208 82.1 74.4 16,650 NA NA
Costa Rica 1965–1995 4,669,685 81.7 77.0 6,910 1,167 9.7
Denmark 1955–2005 5,547,683 81.2 77.1 60,820 4,545 11.1
United States of America 1950–2005 309,326,295 81.0 76.2 49,110 8,299 17.7
Cuba 1970–1995 11,281,768 80.8 76.7 5,630 1,823 10.6
Czechoslovakia, Former 1955–1990 1991: 15,592,000 NA NA NA NA NA
Czech Republic 1990–2010 10,474,410 80.6 74.4 19,210 1,930 7.4
Slovakia 1995–2010 5,391,428 78.8 71.6 17,130 2,039 9.0
Poland 1960–2010 38,183,683 80.6 72.1 12,580 1,432 7.0
Estonia 1985–2010 1,331,475 80.5 70.6 14,390 1,300 6.3
Uruguay 1955–1990 3,371,982 80.2 73.2 10,110 1,423 8.7
Yugoslavia, Former 1965–1990 1990: 23,817,900 NA NA NA NA NA
Croatia 1985–2010 4,417,781 79.6 73.5 13,740 1,607 7.8
Serbia 2000–2010 7,291,436 76.6 71.4 5,850 1,191 10.7
Argentina 1980–1995 40,374,224 79.5 72.0 2005: 4,450 1,312 8.2
Mexico 1960–1995 117,886,404 79.2 74.3 8,730 1,003 6.3
Lithuania 1985–2010 3,097,282 78.8 68.0 12,260 1,387 7.0
Latvia 1980–2010 2,097,555 78.4 68.8 12,680 1,145 6.5
Hungary 1955–2010 10,000,023 78.1 70.5 13,050 1,701 8.0
Armenia 1985–2000 2,963,496 77.7 70.9 3,370 291 4.6
Romania 1970–2010 20,246,871 77.3 69.8 8,430 964 5.9
Venezuela 1955–1990 29,043,283 77.2 71.3 11,520 795 4.7
Bulgaria 1965–2010 7,395,599 77.2 70.0 6,630 1,088 7.6
TFYR Macedonia 1995–2010 2,102,216 77.0 72.5 4,570 778 7.0
Mauritius 1965–2005 1,280,924 76.7 69.5 7,780 813 5.4
Belarus 1985–1995 9,490,000 76.5 64.6 5,990 855 5.6
China,select urban and rural areas 1990–2000 1,337,705,000 76.2 73.6 4,240 441 5.0
Ukraine 1985–2005 45,870,700 75.5 65.3 2,990 599 7.8
Kuwait 1975–2000 2,991,580 75.1 73.2 42,920 2,286 2.8
Russian Federation 1980–2010 142,385,523 74.9 63.1 10,010 1,410 6.3
Azerbaijan 1985–2000 9,054,332 73.6 67.4 5,370 831 5.3
Kyrgyzstan 1985–2005 5,447,900 73.5 65.3 850 186 6.7
Trinidad and Tobago 1970–1990 1,328,095 73.3 66.1 15,800 1,494 5.2
Kazakhstan 1985–2010 16,321,581 73.3 63.5 7,440 871 4.3
Republic of Moldova 1985–2010 3,562,045 72.4 64.7 1,820 448 11.7
Uzbekistan 1985–2005 28,562,400 71.3 64.6 1,300 226 5.4
Tajikistan 1985–2000 7,627,326 70.4 63.8 730 125 6.0
Turkmenistan 1985–1995 5,041,995 69.3 60.9 4,070 196 2.1

  1. Countries with high life expectancy but varying health expenditures who were selected for in-depth analyses are highlighted in bold text
  2. aData from the year 2010 unless otherwise noted
  3. bData from World Bank
  4. cHealth expenditure per capita in international $ considering country-specific purchasing power parity (PPP) rates

Última postagem

Tag